Atara Biotherapeutics (ATRA) Non-Current Deffered Revenue (2020 - 2024)
Atara Biotherapeutics (ATRA) recorded Non-Current Deffered Revenue of $470,000 in Q3 2024, down 99.4% from $73.93 million a year earlier and down 17.1% from the prior quarter.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Non-Current Deffered Revenue (2020 - 2024) Analysis & Trends
At the end of FY2023, Atara Biotherapeutics reported Non-Current Deffered Revenue of $37.56 million, down 51.2% from FY2022.
- Annual Non-Current Deffered Revenue has a three-year compound annual growth rate of 10.6% (FY2020 to FY2023).
- Across earlier years, Non-Current Deffered Revenue came in at $77 million in FY2022 (+38.2%), $55.71 million in FY2021 (+100.4%) and $27.8 million in FY2020.
- The Q3 2024 figure is the lowest quarterly Non-Current Deffered Revenue in data going back to Q4 2020.
- On a year-over-year basis, Non-Current Deffered Revenue has declined for four consecutive quarters, with an average decline of 11.0% over the last eight quarters.
- Peak year-over-year performance for Non-Current Deffered Revenue in the last five years was growth of 100.4% in Q4 2021, against a decline of 99.4% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $567,000 (Q2 2024), $719,000 (Q1 2024) and $37.56 million (Q4 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Atara Biotherapeutics | 127.78 Mn | 117.88 Mn | 439,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 470,000.00 |
| Jun 30, 2024 | 567,000.00 |
| Mar 31, 2024 | 719,000.00 |
| Dec 31, 2023 | 37.56 Mn |
| Sep 30, 2023 | 73.93 Mn |
| Jun 30, 2023 | 75.57 Mn |
| Mar 31, 2023 | 78.04 Mn |
| Dec 31, 2022 | 77.00 Mn |
| Sep 30, 2022 | 42.34 Mn |
| Jun 30, 2022 | 43.33 Mn |
| Mar 31, 2022 | 45.00 Mn |
| Dec 31, 2021 | 55.71 Mn |
| Sep 30, 2021 | 26.84 Mn |
| Jun 30, 2021 | 22.47 Mn |
| Mar 31, 2021 | 31.81 Mn |
| Dec 31, 2020 | 27.80 Mn |
API Access
Atara Biotherapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();